Stryker Corporation 0R2S.L Stock
Stryker Corporation Price Chart
Stryker Corporation 0R2S.L Financial and Trading Overview
Stryker Corporation stock price | 333.55 USD |
Previous Close | 294.77 USD |
Open | 0 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 305.82 USD |
Volume | 456 USD |
Avg. Volume | 5.22K USD |
Market Cap | 1.09B USD |
Beta (5Y Monthly) | 0.95 |
PE Ratio (TTM) | 0.5580148 |
EPS (TTM) | 5.26 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0R2S.L Valuation Measures
Enterprise Value | 123.7B USD |
Trailing P/E | 0.5580148 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.05761382 |
Price/Book (mrq) | 6.5937176 |
Enterprise Value/Revenue | 6.527 |
Enterprise Value/EBITDA | 26.614 |
Trading Information
Stryker Corporation Stock Price History
Beta (5Y Monthly) | 0.95 |
52-Week Change | 50.27% |
S&P500 52-Week Change | 20.43% |
52 Week High | 305.82 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 286.44 USD |
200-Day Moving Average | 251.7 USD |
0R2S.L Share Statistics
Avg. Volume (3 month) | 5.22K USD |
Avg. Daily Volume (10-Days) | 16.56K USD |
Shares Outstanding | 374.19M |
Float | 338.98M |
Short Ratio | N/A |
% Held by Insiders | 6.47% |
% Held by Institutions | 80.08% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.89 |
Trailing Annual Dividend Yield | 0.98% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 13.86% |
Operating Margin (ttm) | 19.17% |
Gross Margin | 62.91% |
EBITDA Margin | 24.52% |
Management Effectiveness
Return on Assets (ttm) | 6.22% |
Return on Equity (ttm) | 16.44% |
Income Statement
Revenue (ttm) | 18.95B USD |
Revenue Per Share (ttm) | 50.07 USD |
Quarterly Revenue Growth (yoy) | 11.79% |
Gross Profit (ttm) | 11.65B USD |
EBITDA | 4.65B USD |
Net Income Avi to Common (ttm) | 2.63B USD |
Diluted EPS (ttm) | 5.259 |
Quarterly Earnings Growth (yoy) | 83.29% |
Balance Sheet
Total Cash (mrq) | 1.76B USD |
Total Cash Per Share (mrq) | 4.63 USD |
Total Debt (mrq) | 13.56B USD |
Total Debt/Equity (mrq) | 80.26 USD |
Current Ratio (mrq) | 1.731 |
Book Value Per Share (mrq) | 44.506 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.87B USD |
Levered Free Cash Flow (ttm) | 1.85B USD |
Profile of Stryker Corporation
Country | United Kingdom |
State | MI |
City | Kalamazoo |
Address | 2825 Airview Boulevard |
ZIP | 49002 |
Phone | 269 385 2600 |
Website | https://www.stryker.com |
Industry | |
Sector(s) | |
Full Time Employees | 51000 |
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Q&A For Stryker Corporation Stock
What is a current 0R2S.L stock price?
Stryker Corporation 0R2S.L stock price today per share is 333.55 USD.
How to purchase Stryker Corporation stock?
You can buy 0R2S.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Stryker Corporation?
The stock symbol or ticker of Stryker Corporation is 0R2S.L.
How many shares does Stryker Corporation have in circulation?
The max supply of Stryker Corporation shares is 3.72M.
What is Stryker Corporation Price to Earnings Ratio (PE Ratio)?
Stryker Corporation PE Ratio is 0.63424605 now.
What was Stryker Corporation earnings per share over the trailing 12 months (TTM)?
Stryker Corporation EPS is 5.26 USD over the trailing 12 months.